関連する実験動画
Updated: Nov 12, 2025

10:30
Visualization of IL-22-expressing Lymphocytes Using Reporter Mice
Published on: January 25, 2017
9.1K
インタールイキン10のプロおよび抗炎症機能の構造に基づく解離
Robert A Saxton1,2, Naotaka Tsutsumi1,2, Leon L Su1
1Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94305, USA.
まとめ
研究者らは,インタールイキン-10 (IL-10) 受容体複合体の構造を明らかにし,IL-10を選択的に調節する方法を示しました.
科学分野:
- 免疫学
- 構造生物学
- 分子生物学
背景:
- インタールイウキン10 (IL-10) は,抗炎症と免疫刺激の両方の機能を有する重要な免疫調節性サイトカインです.
- IL-10のシグナル伝達機能の低下は,様々な疾患に関与しており,その活動に対する正確な制御の必要性を強調しています.
研究 の 目的:
- インタールイキン10受容体 (IL-10R) 複合体の高解像度構造を決定する.
- IL-10のプレイオトロプ的効果の基礎にある分子機構を理解する.
- 生物学的活動に合わせた IL-10 変種を設計するための構造的基礎を提供する.
主な方法:
- クリオ電子顕微鏡 (cryo-EM) を利用して,IL-10R複合体の構造を3. 5アングストームの解像度で解明した.
- 改変されたIL-10Rβ結合親和性を持つIL-10変種を設計および分析するために,構造ベースのアプローチを採用した.
- 異なる免疫細胞集団におけるこれらの変異の機能的影響を調査した.
主要な成果:
- ヘクサメリック構造は,IL-10とIL-10RαがIL-10Rβを巻き込むための複合表面を作成する方法を示しています.
- IL- 10Rβ結合強度が変化したIL- 10変種は,様々な免疫細胞において,異なる応答値を示した.
- 特定の変種は,炎症性CD8+T細胞を節約しながら,マクロファージの活性化を抑制し,重要なIL-10機能を解き放った.
結論:
- 決定されたIL-10R複合構造は,IL-10シグナリングを理解するためのメカニズム的な青写真を提供します.
- この構造的洞察は,部分IL-10アゴニストと細胞型選択変調剤の合理的な設計を可能にします.
- この発見は,疾患の文脈でIL-10のプレイオトロプ的作用を治療的に調整するための新しい戦略を提供します.
関連する概念動画
T Cell Types and Functions
1.7K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.7K
Inflammatory Response
14.9K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
14.9K
The JAK-STAT Signaling Pathway
10.1K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
10.1K
NF-κB-dependent Signaling Pathway
8.5K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
8.5K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
287
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
287
TGF - β Signaling Pathway
8.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
8.3K

